Literature DB >> 18945785

Deletions of the hypervariable region (HVR) in open reading frame 1 of hepatitis E virus do not abolish virus infectivity: evidence for attenuation of HVR deletion mutants in vivo.

R S Pudupakam1, Y W Huang, T Opriessnig, P G Halbur, F W Pierson, X J Meng.   

Abstract

Hepatitis E virus (HEV) is an important human pathogen, although little is known about its biology and replication. Comparative sequence analysis revealed a hypervariable region (HVR) with extensive sequence variations in open reading frame 1 of HEV. To elucidate the role of the HVR in HEV replication, we first constructed two HVR deletion mutants, hHVRd1 and hHVRd2, with in-frame deletion of amino acids (aa) 711 to 777 and 747 to 761 in the HVR of a genotype 1 human HEV replicon. Evidence of HEV replication was detected in Huh7 cells transfected with RNA transcripts from mutant hHVRd2, as evidenced by expression of enhanced green fluorescent protein. To confirm the in vitro results, we constructed three avian HEV mutants with various HVR deletions: mutants aHVRd1, with deletion of aa 557 to 585 (Delta557-585); aHVRd2 (Delta612-641); and aHVRd3 (Delta557-641). Chickens intrahepatically inoculated with capped RNA transcripts from mutants aHVRd1 and aHVRd2 developed active viral infection, as evidenced by seroconversion, viremia, and fecal virus shedding, although mutant aHVRd3, with complete HVR deletion, was apparently attenuated in chickens. To further verify the results, we constructed four additional HVR deletion mutants using the genotype 3 swine HEV as the backbone. Mutants sHVRd2 (Delta722-781), sHVRd3 (Delta735-765), and sHVRd4 (Delta712-765) were shown to tolerate deletions and were infectious in pigs intrahepatically inoculated with capped RNA transcripts from the mutants, whereas mutant sHVRd1 (Delta712-790), with a nearly complete HVR deletion, exhibited an attenuation phenotype in infected pigs. The data from these studies indicate that deletions in HVR do not abolish HEV infectivity in vitro or in vivo, although evidence for attenuation was observed for HEV mutants with a larger or nearly complete HVR deletion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945785      PMCID: PMC2612298          DOI: 10.1128/JVI.01854-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.

Authors:  Suzanne U Emerson; Hanh Nguyen; Udana Torian; Robert H Purcell
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

2.  A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis.

Authors:  Y Wang; R Ling; J C Erker; H Zhang; H Li; S Desai; I K Mushahwar; T J Harrison
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

3.  Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4.

Authors:  Y Wang; H Zhang; Z Li; W Gu; H Lan; W Hao; R Ling; H Li; T J Harrison
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 4.  Hepatitis E.

Authors:  K Krawczynski
Journal:  Hepatology       Date:  1993-05       Impact factor: 17.425

5.  Systematic pathogenesis and replication of avian hepatitis E virus in specific-pathogen-free adult chickens.

Authors:  P Billam; F F Huang; Z F Sun; F W Pierson; R B Duncan; F Elvinger; D K Guenette; T E Toth; X J Meng
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States.

Authors:  F F Huang; G Haqshenas; D K Guenette; P G Halbur; S K Schommer; F W Pierson; T E Toth; X J Meng
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Development and validation of a negative-strand-specific reverse transcription-PCR assay for detection of a chicken strain of hepatitis E virus: identification of nonliver replication sites.

Authors:  P Billam; F W Pierson; W Li; T LeRoith; R B Duncan; X J Meng
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

8.  Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?

Authors:  S S Hamid; S M Jafri; H Khan; H Shah; Z Abbas; H Fields
Journal:  J Hepatol       Date:  1996-07       Impact factor: 25.083

9.  Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent.

Authors:  V A Arankalle; M S Chadha; S A Tsarev; S U Emerson; A R Risbud; K Banerjee; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses.

Authors:  E V Koonin; A E Gorbalenya; M A Purdy; M N Rozanov; G R Reyes; D W Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

View more
  46 in total

1.  Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination.

Authors:  P Shukla; H T Nguyen; K Faulk; K Mather; U Torian; R E Engle; S U Emerson
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

2.  Cross-species infection of pigs with a novel rabbit, but not rat, strain of hepatitis E virus isolated in the United States.

Authors:  Caitlin M Cossaboom; Laura Córdoba; Brenton J Sanford; Pablo Piñeyro; Scott P Kenney; Barbara A Dryman; Youchun Wang; Xiang-Jin Meng
Journal:  J Gen Virol       Date:  2012-04-25       Impact factor: 3.891

3.  Full-length sequence analysis of hepatitis E virus isolates: showing potential determinants of virus genotype and identity.

Authors:  Dong Yang; Mei Jiang; Min Jin; Zhigang Qiu; Weihong Cui; Zhiqiang Shen; Bo Li; Lianfeng Gong; Zhaoli Chen; Xinwei Wang; Jun-Wen Li
Journal:  Virus Genes       Date:  2013-07-26       Impact factor: 2.332

4.  Evolution of the hepatitis E virus polyproline region: order from disorder.

Authors:  Michael A Purdy
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture.

Authors:  H T Nguyen; U Torian; K Faulk; K Mather; R E Engle; E Thompson; H L Bonkovsky; S U Emerson
Journal:  J Gen Virol       Date:  2011-11-23       Impact factor: 3.891

Review 6.  Hepatitis E Virus Genome Structure and Replication Strategy.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

7.  Intergenotypic chimeric hepatitis E viruses (HEVs) with the genotype 4 human HEV capsid gene in the backbone of genotype 3 swine HEV are infectious in pigs.

Authors:  Alicia R Feagins; Laura Córdoba; Brent J Sanford; Barbara A Dryman; Yao-Wei Huang; Tanya LeRoith; Suzanne U Emerson; Xiang-Jin Meng
Journal:  Virus Res       Date:  2010-12-30       Impact factor: 3.303

8.  Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant.

Authors:  Priyanka Shukla; Hanh T Nguyen; Udana Torian; Ronald E Engle; Kristina Faulk; Harry R Dalton; Richard P Bendall; Frances E Keane; Robert H Purcell; Suzanne U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

Review 9.  Naturally occurring animal models of human hepatitis E virus infection.

Authors:  Danielle M Yugo; Caitlin M Cossaboom; Xiang-Jin Meng
Journal:  ILAR J       Date:  2014

10.  Rescue of a genotype 4 human hepatitis E virus from cloned cDNA and characterization of intergenotypic chimeric viruses in cultured human liver cells and in pigs.

Authors:  Laura Córdoba; Alicia R Feagins; Tanja Opriessnig; Caitlin M Cossaboom; Barbara A Dryman; Yao-Wei Huang; Xiang-Jin Meng
Journal:  J Gen Virol       Date:  2012-07-25       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.